The Preclinical Therapeutics Program is a complete solution for the design, planning, coordination and execution of preclinical therapeutic studies, providing technical expertise often not available within individual labs.
The Preclinical Therapeutics Program (PTP) provides a complete solution for the design, planning, coordination and execution of preclinical therapeutic studies for Cancer Center members. This resource is available to all St. Jude investigators whether they have experience in preclinical studies or not, providing technical expertise often not available within individual labs. Acting within the Center for In Vivo Imaging and Therapeutics (CIVIT), staff coordinate activities for these studies including advanced imaging (MRI, PET/CT), image-guided radiation treatment, ultrasound, and surgical procedures required for specific study designs. Dedicated PTP staff support peer reviewed studies prioritized by Cancer Center Programs, providing hands-on expertise for conducting pharmacokinetic studies, dosing, imaging, and health observations of on-study animals.
PTP aims to provide complete study management and performance within a small core, minimizing the number of individuals involved and reduce the potential for errors in communication. The technical resources of CIVIT, dedicated project management, and tumor resources of the cancer programs provide an exceptional resource to provide preclinical data required for developing clinical trials in pediatric cancer.
PTP has been instrumental in advancing in vivo experiments in my lab. The process is very streamlined: after submitting an application, you obtain expert input during the review process, while also having access to many technical and imaging resources. PTP staff is very enthusiastic, resulting in very productive collaborations.
Paulina Velasquez, Assistant Member
Services and Capabilities
peer-reviewed publication contributions
grants funded using PTP